Salvage Therapy for Hodgkin’s Lymphoma: A Review of Current Regimens and Outcomes
Author:
Publisher
Informa UK Limited
Subject
Hematology
Reference109 articles.
1. Dose Intensity of Chemotherapy in Patients With Relapsed Hodgkin's Lymphoma
2. Normalization of pre-ASCT, FDG-PET imaging with second-line, non–cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma
3. Risk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma
4. Prognostic value of pretransplant FDG-PET in refractory/relapsed Hodgkin lymphoma treated with autologous stem cell transplantation: systematic review and meta-analysis
5. A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Safety and efficacy of immune checkpoint inhibitors after allogeneic hematopoietic cell transplantation;Bone Marrow Transplantation;2023-07-29
2. The role of transplantation in Hodgkin lymphoma;Frontiers in Oncology;2023-01-26
3. Treatment patterns and clinical outcomes among patients with relapsed/refractory classical Hodgkin's lymphoma;Future Oncology;2022-10
4. Own experience in the treatment of primary refractory Hodgkin's lymphoma. Case report;Journal of Modern Oncology;2022-07-15
5. Immune Checkpoint Blockade for the Treatment of Hodgkin Lymphoma;ImmunoTargets and Therapy;2022-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3